Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pomalidomide, Atc L04Ax06 For The Period June 1St, 2026 - May 31St, 2028 (Plus Extension Option 1X12 Months)